-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.00263.64% Upside
LAVA Therapeutics N.V. Frequently Asked Questions
-
What analysts cover LAVA Therapeutics N.V.?
LAVA Therapeutics N.V. has been rated by research analysts at H.C. Wainwright, Jefferies in the past 90 days.